Abstract : Migraine headache is an episodic primary headache disorder [1], [2], affecting about one in 10 adults worldwide [3]. Variety of drugs are available for both preventive [4], [5] and acute treatment [1], [4- 6]. However, many drugs may have varieties of adverse reaction [4- 8]. Recently, repetitive transcranial magnetic stimulation (rTMS) [9] has emerged as treatment option for episodic migraine [10], [11]. Single centre open labelled study. A total of 30 subjects with episodic migraine are included. Set of questionnaire used for recording on the headache frequency, headache severity during each attack, number of medications intake during migraine headache as well as for prophylaxis. All subjects will receive a total of 3 rTMS sessions, to be completed within a week. Upon completion, subjects will be evaluated with the same set of questionnaire. A month after completion of all rTMS sessions, 53.3% of subjects showed improvement of > 50% headache frequency. The number of rescue medications intake before rTMS was at mean 12.2 (SD 7.04) vs 2.57 (SD 2.14) at 4 weeks. Headache severity showed a mean score 7.4 (SD 1.55) reduced to 1.97 (SD 2.04) at the 1st week and 2.47 (SD: 1.81) on the 2nd week post rTMS. On the 3rd and 4th week, the mean score increased to 3.43 (SD 2.25) and 4.13 (SD 1.72) respectively. Treatment with rTMS is beneficial among Malaysia population suffer from episodic migraine. Improvement in terms of headache frequency, headache severity as well as reduction of numbers of abortive medications intake have been reported and confirmed in this study.